PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,306 | +6.8% | 53,470 | +8.9% | 0.00% | – |
| Q2 2023 | $307,303 | +38.5% | 49,090 | +5.6% | 0.00% | – |
| Q1 2023 | $221,805 | -38.3% | 46,500 | +12.6% | 0.00% | – |
| Q4 2022 | $359,310 | -26.8% | 41,300 | 0.0% | 0.00% | – |
| Q3 2022 | $491,000 | +7.9% | 41,300 | +29.5% | 0.00% | – |
| Q2 2022 | $455,000 | +32.3% | 31,900 | +93.3% | 0.00% | – |
| Q1 2022 | $344,000 | -9.7% | 16,500 | 0.0% | 0.00% | – |
| Q4 2021 | $381,000 | -3.1% | 16,500 | +25.0% | 0.00% | – |
| Q3 2021 | $393,000 | -40.7% | 13,200 | -32.0% | 0.00% | – |
| Q2 2021 | $663,000 | +105.9% | 19,400 | +98.0% | 0.00% | – |
| Q1 2021 | $322,000 | -43.7% | 9,800 | +5.4% | 0.00% | – |
| Q4 2020 | $572,000 | – | 9,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |